100 related articles for article (PubMed ID: 20171438)
1. [Multiple lesions of focal cutaneous mucinosis: a side-effect of anti-TNF alpha therapy?].
Duparc A; Gosset P; Lasek A; Modiano P
Ann Dermatol Venereol; 2010 Feb; 137(2):140-2. PubMed ID: 20171438
[No Abstract] [Full Text] [Related]
2. [Infliximab].
Herrera E; Habicheyn S
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
[TBL] [Abstract][Full Text] [Related]
3. [Infectious risk].
Calabuig E; Salavert M
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity by anti-tumour necrosis factor-alpha agents: the role of traditional therapies.
Antoniou C; Moustou AE; Vergou T; Stratigos A; Kalambokas A; Katsambas AD
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):356-7. PubMed ID: 19686257
[No Abstract] [Full Text] [Related]
5. Gastric MALT lymphoma in a patient receiving infliximab for psoriasis.
Girard C; Guillot B; Bessis D
Br J Dermatol; 2008 Aug; 159(2):497-8. PubMed ID: 18547313
[No Abstract] [Full Text] [Related]
6. Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriaisis.
Fairhurst DA; Sheehan-Dare R
Clin Exp Dermatol; 2009 Apr; 34(3):421-2. PubMed ID: 19309375
[No Abstract] [Full Text] [Related]
7. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.
Tan MH; Gordon M; Lebwohl O; George J; Lebwohl MG
Arch Dermatol; 2001 Jul; 137(7):930-3. PubMed ID: 11453813
[TBL] [Abstract][Full Text] [Related]
8. Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17a.
Leonardi CL
Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S74-7. PubMed ID: 27551698
[TBL] [Abstract][Full Text] [Related]
9. New development in the treatment of psoriasis--infliximab.
Pietrzak A; Chodorowska G; Jazienicka I; Junak-Bojarska A; Roliński J
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):322-7. PubMed ID: 15315008
[TBL] [Abstract][Full Text] [Related]
10. Infliximab and nephrotic syndrome.
Chin G; Luxton G; Harvey JM
Nephrol Dial Transplant; 2005 Dec; 20(12):2824-6. PubMed ID: 16204273
[TBL] [Abstract][Full Text] [Related]
11. Infliximab-induced lichen planopilaris.
Fernández-Torres R; Paradela S; Valbuena L; Fonseca E
Ann Pharmacother; 2010 Sep; 44(9):1501-3. PubMed ID: 20702759
[TBL] [Abstract][Full Text] [Related]
12. [Up-date on the use of infliximab in dermatology. Introduction].
Sánchez-Carazo J
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():1. PubMed ID: 19080984
[No Abstract] [Full Text] [Related]
13. Psoriasis and its treatment with infliximab-mediated tumor necrosis factor alpha blockade.
Winterfield L; Menter A
Dermatol Clin; 2004 Oct; 22(4):437-47, ix. PubMed ID: 15450339
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune hepatitis in two psoriasis patients treated with inflixmab.
Goujon C; Dahel K; Bérard F; Guillot I; Gunera-Saad N; Nicolas JF
J Am Acad Dermatol; 2010 Aug; 63(2):e43-4. PubMed ID: 20633783
[No Abstract] [Full Text] [Related]
15. Use of infliximab in the treatment of psoriasis.
Lee MR; Cooper AJ
Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904
[No Abstract] [Full Text] [Related]
16. Early videocapillaroscopic changes of the psoriatic skin after anti-tumour necrosis factor alpha treatment.
De Angelis R; Gasparini S; Bugatti L; Filosa G
Dermatology; 2005; 210(3):241-3. PubMed ID: 15785057
[No Abstract] [Full Text] [Related]
17. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?
Roux CH; Brocq O; Leccia N; Giacchero D; Breuil V; Albert C; Lacour J; Perrin C; Euller-Ziegler L
J Rheumatol; 2007 Feb; 34(2):434-7. PubMed ID: 17295430
[TBL] [Abstract][Full Text] [Related]
18. Infliximab-induced pityriasis lichenoides chronica in a patient with psoriasis.
Newell EL; Jain S; Stephens C; Martland G
J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):230-1. PubMed ID: 18680531
[No Abstract] [Full Text] [Related]
19. Switching between antitumour necrosis factor alpha biologic agents--is patient weight an important consideration?
Downs AM
Br J Dermatol; 2009 May; 160(5):1123-4. PubMed ID: 19292716
[No Abstract] [Full Text] [Related]
20. New Therapies for Psoriasis.
Leonardi CL
Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S71-3. PubMed ID: 27525355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
